BiochemistrybioRxiv
A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL
B. Tong, J. N. Spradlin, L. F. T. Novaes…·D. K. Nomura
This paper develops a PROTAC molecule, BT1, that selectively degrades BCR-ABL over c-ABL in leukemia cells using nimbolide as an E3 ligase recruiter, showing additional anti-proliferative effects.
DOI 10.1021/acschembio.0c00348